Laxmi Organic Industries Ltd. · NSE:LXCHEM
Laxmi Organic Industries — Q1 FY23 Earnings Presentation
18 slides from Laxmi Organic Industries's earnings presentation, Jul 28, 2022
Slide 1: Exchange intimation letter for analyst meet
July 28, 2022 BSE Limited National Stock Exchange of India Limited Corporate Relationship Department, Exchange Plaza, Bandra Kurla Complex, 1st Floor, New Trading Ring, Bandra (E), Rotunda Building, P. J. Towers, Mumbai – 400 051 Dalal Street, Fort, Trading Symbol: LXCHEM Mumbai – 400 001 Scrip Code
Slide 2: Investor Presentation – Q1FY23
Laxmi Organic Industries Ltd Investor Presentation– Q1FY23 28th July 2022 LAXMI ORGANIC INDUSTRIES LTD
Slide 3: Disclaimer
Disclaimer This presentation and the accompanying slides (the “Presentation”), which have been prepared by Laxmi Organics Limited (the “Company”) solely for the information purposes and do not constitute any offer, recommendation or invitation to purchase or subscribe for any securities and shall no
Slide 4: The Journey So Far
The Journey So Far Entered Specialty Chemicals business – Glacial Acetic Acquisition of Clariant’s diketene Entry into fluorospecialty business – Acid mfg business Acquisition of Miteni, Italy assets facility estd 2 windmills of Hydro-electric power 0.6MW each project installed commissioned 2010 201
Slide 5: Consolidating Growth over the Years
Consolidating Growth over the Years Particulars FY11-FY14 FY15-FY18 FY19-FY22 AI Revenue Contribution 77% 63% 60% SI Revenue Contribution 23% 37% 40% EBITDA CAGR (%) 4% 22% 31% Average Annual Capex (Rs cr) 46.7 49.3 62.3 Average D/E (x) 1.06 0.66 0.12 o Better o Speciality o Strong Margins chemicals
Slide 6: Stable, Growing & Diversified Business
Stable, Growing & Diversified Business AI SI FI Acetyl Specialty Fluoro-Specialty Intermediaries Intermediaries Intermediaries o #1 in India o #1 in India o USD 4.0bn GTM opportunity o Top 5 in the world o Very strong NPD o World class technology o High & growing contracted revenue o Customer approv
Slide 7: De-risked Business Model
De-risked Business Model Robust Export Share in Sales Diversified Industry Base (INR Mn) Domestic Export Pharmaceuticals 5,046 5,046 4,777 4,438 32% 23% Agrochemicals FY22 3,131 3,324 2,928 3,066 Colour and 6% pigment 2% 1,407 1,340 Printing and 2% Packaging 35% Coating Q1 FY23 Q4 FY22 Q3 FY22 Q2 FY
Slide 8: Q1FY23 Performance
Q1FY23 Performance LAXMI ORGANIC INDUSTRIES LTD
Slide 9: Key Developments in Q1 FY23 - SI
Key Developments in Q1 FY23- SI Product Mix Optimisation - Rebased Specialty Intermediaries – Market Overview 100 100 96 o We continue to maintain our leading market share in the domestic market of Diketene derivatives 88 o Given our backward integrated operations, global customers prefer Laxmi supp
Slide 10: Key Developments in Q1 FY23 - AI
Key Developments in Q1 FY23- AI ETAC FOB (USD/t) 1,600 Acetyls Intermediary – Market Overview 1,400 1,200 1,000 800 o Domestic ETAC prices remained flat in Q1 FY23 vs Q4 FY22 600 400 o Acetic acid prices saw softening and we optimized RM purchase 200 between local supplies and imports - 06-Jun-22 06
Slide 11: Key Developments in Q1 FY23 - FI
Key Developments in Q1 FY23 - FI Fluoro Specialty – Project Overview Fluoro Specialty – Customer Overview o Significant progress has been made in India o Samples for initial ca. 8 products approved with almost 95% of the civil and structural by customers work being complete o Customer contract negot
Slide 12: Financial Highlights: Q1FY23
Financial Highlights: Q1FY23 SALES EBITDA PAT EPS (INR Mn) (INR Mn) (INR Mn) (INR) Q1’FY23 ₹ 7,566 ₹ 1,036 ₹ 649 ₹ 2.45 YOY: + 2.8% - 30.7% - 37.1% - 37.1% QOQ: - 14.0% + 38.3% + 12.9 % + 12.9 % Q1’FY22 ₹ 7,364 ₹ 1,453 ₹ 1,023 ₹ 3.58 Q4’FY22 ₹ 8,798 ₹ 729 ₹ 575 ₹ 2.30 Improved margins in Q1 FY2023 L
Slide 13: Company Performance – Contribution from AI & SI
Company Performance – Contribution from AI & SI AI business SI business Contribution to Top-line 65% Contribution to Top-line 35% Contribution to Profits 50% Contribution to Profits 50% Exports 40% Exports 40% Strong performance of both business segments has started FY23 on a strong foot
Slide 14: QoQ PAT Improvement
QoQ PAT Improvement Improved material, employee and finance costs have improved QoQ PAT
Slide 15: Quarterly Performance
Quarterly Performance Particulars (In INR Mn) Q1FY23 Q4FY22 QoQ (%) Q1FY22 YoY (%) Revenue from Operations 7,566 8,799 -14.0% 7,364 2.8% Other Income 21 19 15.8% 43 -50% Total Income 7,587 8,818 -14.0% 7,407 2.4% Cost of Materials 4,569 6,138 -25.6% 4,774 -4.3% Gross Profits 3,018 2,680 12.6% 2,633
Slide 16: Capex Overview
Capex Overview Capex Overview for FY 23 Funding of Capex Debottlenecking capex in AI – less than 5% of IPO process of > INR 100cr available at the annual capex beginning of the fiscal Growth capex in SI – ca. 42% of the annual Cash flow from operations available capex Deleveraged balance sheet – neg
Slide 17: Delivering Shared Value to all Stakeholders
Delivering Shared Value to all Stakeholders CUSTOMER INTERGRITY SUSTAINABILTY INNOVATION CENTRICITY o Always on the lookout for o Proud partner of many o Signatories to Responsible o To create a culture of customer-specific and well established and well- Care- a voluntary innovation where failure ma
Slide 18: Thank You
THANK YOU For further information, please get in touch with: Monali Jain Aniket Hirpara monali@GoIndiaadvisors.com aniket.hirpara@laxmi.com M:+91 7597304020 M:+91 7666830913
Laxmi Organic Industries — Q1 FY23 Earnings Presentation on 6ix